Condition
Hemorrhoid Bleeding
Total Trials
6
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting3
Completed2
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07264413Not Yet Recruiting
Bleeding Reduction in Grade II-III Haemorrhoids Through Embolization Treatment
NCT05089500Not ApplicableCompleted
Endoscopic Injection Sclerotherapy Versus Endoscopic Band Ligation for Grade I-III Internal Hemorrhoids
NCT07635784Recruiting
Prospective HemorrhoIdaL EmboliSation (PILES) Registry
NCT07295886RecruitingPrimary
Topical Nifedipine 0.3% Plus Lidocaine 1.5% for Uncomplicated Hemorrhoidal Disease
NCT06625138Not ApplicableRecruiting
Trial of Latex Vs Non-latex Hemorrhoid Banding
NCT03060616CompletedPrimary
Validation of Hemorrhoidal Bleeding Score
Showing all 6 trials